Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-κB pathway

RNA Biology

Volumn 13, Issue 1, 2016, Pages 98-108

  Zhou, Xiao ^a   Han, Xiaorui ^a   Wittfeldt, Ann ^b   Sun, Jingzhi ^c   Liu, Chujun ^a   Wang, Xiaoxia ^a   Gan, Li Ming ^b,d   Cao, Huiqing ^a   Liang, Zicai ^a  

^a PEKING UNIVERSITY   (China)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c JINING MEDICAL UNIVERSITY   (China)

^d ASTRAZENECA R AND D   (Sweden)

Author keywords

ANRIL; Coronary artery disease; Inflammation; Long non coding RNA; NF B; YY1

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; INTERLEUKIN 6; INTERLEUKIN 8; LONG UNTRANSLATED RNA; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; RNA; TRANSCRIPTION FACTOR YY1; TUMOR NECROSIS FACTOR ALPHA; ANRIL LONG NON-CODING RNA, HUMAN; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR; YY1 PROTEIN, HUMAN;

ADULT; ANTISENSE NONCODING RNA IN THE INK4 LOCUS GENE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; FEMALE; GENE; GENE CONTROL; GENE FUNCTION; GENE LOCUS; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INFLAMMATION; MALE; MIDDLE AGED; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY MECHANISM; RNA SEQUENCE; CELL LINE; DRUG EFFECTS; GENETICS; IMMUNOLOGY; PROMOTER REGION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

CELL LINE; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; NF-KAPPA B; PROMOTER REGIONS, GENETIC; RNA, LONG NONCODING; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; YY1 TRANSCRIPTION FACTOR;

EID: 84964066198     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.1080/15476286.2015.1122164     Document Type: Article

References (65)

1. Griffiths-Jones S. Annotating noncoding RNA genes. Annu Rev Genomics Hum Genet 2007; 8:279–98; PMID:17506659; http://dx.doi.org/10.1146/annurev.genom.8.080706.092419
2. Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, Stadler PF, Hertel J, Hackermuller J, Hofacker IL, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007; 316:1484–8; PMID:17510325; http://dx.doi.org/10.1126/science.1138341
3. Yang L, Froberg JE, Lee JT. Long noncoding RNAs: fresh perspectives into the RNA world. Trends Biochem Sci 2014; 39:35–43; PMID:24290031; http://dx.doi.org/10.1016/j.tibs.2013.10.002
4. Ghazal S, McKinnon B, Zhou J, Mueller M, Men Y, Yang L, Mueller M, Flannery C, Huang Y, Taylor HS. H19 lncRNA alters stromal cell growth via IGF signaling in the endometrium of women with endometriosis. EMBO Mol Med 2015; 7:996–1003; PMID:26089099; http://dx.doi.org/10.15252/emmm.201505245
5. Michalik KM, You X, Manavski Y, Doddaballapur A, Zornig M, Braun T, John D, Ponomareva Y, Chen W, Uchida S, et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res 2014; 114:1389–97; PMID:24602777; http://dx.doi.org/10.1161/CIRCRESAHA.114.303265
6. Ng SY, Lin L, Soh BS, Stanton LW. Long noncoding RNAs in development and disease of the central nervous system. Trends Genet 2013; 29:461–8; PMID:23562612; http://dx.doi.org/10.1016/j.tig.2013.03.002
7. Li Z, Chao TC, Chang KY, Lin N, Patil VS, Shimizu C, Head SR, Burns JC, Rana TM. The long noncoding RNA THRIL regulates TNFalpha expression through its interaction with hnRNPL. Proc Natl Acad Sci U S A 2014; 111:1002–7; PMID:24371310; http://dx.doi.org/10.1073/pnas.1313768111
8. Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol 2011; 21:354–61; PMID:21550244; http://dx.doi.org/10.1016/j.tcb.2011.04.001
9. Kataoka M, Wang DZ. Non-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and Disease. Cells 2014; 3:883–98; PMID:25153164; http://dx.doi.org/10.3390/cells3030883
10. Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009; 23:1494–504; PMID:19571179; http://dx.doi.org/10.1101/gad.1800909
11. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, Hinds DA, Pennacchio LA, Tybjaerg-Hansen A, Folsom AR, et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007; 316:1488–91; PMID:17478681; http://dx. doi.org/10.1126/science.1142447
12. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A, Sigurdsson A, Baker A, Palsson A, Masson G, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007; 316:1491–3; PMID:17478679; http://dx. doi.org/10.1126/science.1142842
13. Folkersen L, Kyriakou T, Goel A, Peden J, Malarstig A, Paulsson- Berne G, Hamsten A, Hugh W, Franco-Cereceda A, Gabrielsen A, et al. Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants. PLoS One 2009; 4:e7677; PMID:19888323; http://dx.doi.org/10.1371/journal.pone.0007677
14. Burd CE, Jeck WR, Liu Y, Sanoff HK, Wang Z, Sharpless NE. Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk. PLoS genetics 2010; 6:e1001233; PMID:21151960; http://dx.doi.org/10.1371/journal.pgen.1001233
15. Broadbent HM, Peden JF, Lorkowski S, Goel A, Ongen H, Green F, Clarke R, Collins R, Franzosi MG, Tognoni G, et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 2008; 17:806–14; PMID:18048406; http://dx.doi.org/10.1093/hmg/ddm352
16. Jarinova O, Stewart AF, Roberts R, Wells G, Lau P, Naing T, Buerki C, McLean BW, Cook RC, Parker JS, et al. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler Thromb Vasc Biol 2009; 29:1671–7; PMID:19592466; http://dx.doi.org/10.1161/ATVBAHA.109.189522
17. Liu Y, Sanoff HK, Cho H, Burd CE, Torrice C, Mohlke KL, Ibrahim JG, Thomas NE, Sharpless NE. INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis. PLoS One 2009; 4:e5027; PMID:19343170; http://dx.doi.org/10.1371/journal.pone.0005027
18. Holdt LM, Beutner F, Scholz M, Gielen S, Gabel G, Bergert H, Schuler G, Thiery J, Teupser D. ANRIL expression is associated with atherosclerosis risk at chromosome 9p 21. Arterioscler Thromb Vasc Biol 2010; 30:620–7; PMID:20056914; http://dx.doi.org/10.1161/ATVBAHA.109.196832
19. Cunnington MS, Santibanez Koref M, Mayosi BM, Burn J, Keavney B. Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression. PLoS genetics 2010; 6: e1000899; PMID:20386740; http://dx.doi.org/10.1371/journal.pgen.1000899
20. Congrains A, Kamide K, Ohishi M, Rakugi H. ANRIL: Molecular Mechanisms and Implications in Human Health. Int J Mol Sci 2013; 14:1278–92; PMID:23306151; http://dx.doi.org/10.3390/ijms14011278
21. Roussel MF. The INK4 family of cell cycle inhibitors in cancer. Oncogene 1999; 18:5311–7; PMID:10498883; http://dx.doi.org/10.1038/sj.onc.1202998
22. Yap KL, Li S, Munoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, Gil J, Walsh MJ, Zhou MM. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 2010; 38:662–74; PMID:20541999; http://dx.doi.org/10.1016/j.molcel.2010.03.021
23. Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M, Xiong Y. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 2011; 30:1956–62; PMID:21151178; http://dx.doi.org/10.1038/onc.2010.568
24. Holdt LM, Hoffmann S, Sass K, Langenberger D, Scholz M, Krohn K, Finstermeier K, Stahringer A, Wilfert W, Beutner F, et al. Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS genetics 2013; 9:e1003588; PMID:23861667; http://dx.doi.org/10.1371/journal.pgen.1003588
25. Hasegawa A, Yasukawa M, Sakai I, Fujita S. Transcriptional downregulation of CXC chemokine receptor 4 induced by impaired association of transcription regulator YY1 with c-Myc in human herpesvirus 6-infected cells. J Immunol 2001; 166:1125–31; PMID:11145693; http://dx.doi.org/10.4049/jimmunol.166.2.1125
26. Joo M, Wright JG, Hu NN, Sadikot RT, Park GY, Blackwell TS, Christman JW. Yin Yang 1 enhances cyclooxygenase-2 gene expression in macrophages. Am J Physiol Lung Cell Mol Physiol 2007; 292: L1219–26; PMID:17220375; http://dx.doi.org/10.1152/ajplung.00474.2006
27. Guo J, Casolaro V, Seto E, Yang WM, Chang C, Seminario MC, Keen J, Georas SN. Yin-Yang 1 activates interleukin-4 gene expression in T cells. J Biol Chem 2001; 276:48871–8; PMID:11687571; http://dx.doi.org/10.1074/jbc.M101592200
28. Jeon Y, Lee JT. YY1 tethers Xist RNA to the inactive X nucleation center. Cell 2011; 146:119–33; PMID:21729784; http://dx.doi.org/10.1016/j.cell.2011.06.026
29. Gutierrez E, Flammer AJ, Lerman LO, Elizaga J, Lerman A, Fernandez- Aviles F. Endothelial dysfunction over the course of coronary artery disease. Eur Heart J 2013; 34:3175–81; PMID:24014385; http://dx.doi.org/10.1093/eurheartj/eht351
30. Pate M, Damarla V, Chi DS, Negi S, Krishnaswamy G. Endothelial cell biology: role in the inflammatory response. Adv Clin Chem 2010; 52:109–30; PMID:21275341; http://dx.doi.org/10.1016/S0065-2423(10)52004-3
31. Harismendy O, Notani D, Song X, Rahim NG, Tanasa B, Heintzman N, Ren B, Fu XD, Topol EJ, Rosenfeld MG, et al. 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response. Nature 2011; 470:264–8; PMID:21307941; http://dx.doi.org/10.1038/nature09753
32. Wang J, Zhuang J, Iyer S, Lin X, Whitfield TW, Greven MC, Pierce BG, Dong X, Kundaje A, Cheng Y, et al. Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Res 2012; 22:1798–812; PMID:22955990; http://dx.doi.org/10.1101/gr.139105.112
33. Wang J, Zhuang J, Iyer S, Lin XY, Greven MC, Kim BH, Moore J, Pierce BG, Dong X, Virgil D, et al. Factorbook.org: a Wiki-based database for transcription factor-binding data generated by the ENCODE consortium. Nucleic Acids Res 2013; 41:D171–6; PMID:23203885; http://dx.doi.org/10.1093/nar/gks1221
34. Gerstein MB, Kundaje A, Hariharan M, Landt SG, Yan KK, Cheng C, Mu XJ, Khurana E, Rozowsky J, Alexander R, et al. Architecture of the human regulatory network derived from ENCODE data. Nature 2012; 489:91–100; PMID:22955619; http://dx.doi.org/10.1038/nature11245
35. Moriuchi M, Moriuchi H, Margolis DM, Fauci AS. USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry. J Immunol 1999; 162:5986–92; PMID:10229837
36. Khan R, Spagnoli V, Tardif JC, L’Allier PL. Novel anti-inflammatory therapies for the treatment of atherosclerosis. Atherosclerosis 2015; 240:497–509; PMID:25917947; http://dx.doi.org/10.1016/j.atherosclerosis.2015.04.783
37. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105:1135–43; PMID:11877368; http://dx.doi.org/10.1161/hc0902.104353
38. Li Z, Rana TM. Decoding the noncoding: Prospective of lncRNAmediated innate immune regulation. RNA Biol 2014; 11:979–85; PMID:25482890; http://dx.doi.org/10.4161/rna.29937
39. Fitzgerald KA, Caffrey DR. Long noncoding RNAs in innate and adaptive immunity. Curr Opin Immunol 2014; 26:140–6; PMID:24556411; http://dx.doi.org/10.1016/j.coi.2013.12.001
40. Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 2009; 27:693–733; PMID:19302050; http://dx.doi.org/10.1146/annurev.immunol.021908.132641
41. de Winther MP, Kanters E, Kraal G, Hofker MH. Nuclear factor kappaB signaling in atherogenesis. Arteriosclerosis, thrombosis, and vascular biology 2005; 25:904–14; PMID:15731497; http://dx.doi.org/10.1161/01.ATV.0000160340.72641.87
42. Gareus R, Kotsaki E, Xanthoulea S, van der Made I, Gijbels MJ, Kardakaris R, Polykratis A, Kollias G, de Winther MP, Pasparakis M. Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. Cell Metab 2008; 8:372–83; PMID:19046569; http://dx.doi.org/10.1016/j.cmet.2008.08.016
43. Rapicavoli NA, Qu K, Zhang J, Mikhail M, Laberge RM, Chang HY. A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics. Elife 2013; 2:e00762; PMID:23898399; http://dx.doi.org/10.7554/eLife.00762
44. Carpenter S, Aiello D, Atianand MK, Ricci EP, Gandhi P, Hall LL, Byron M, Monks B, Henry-Bezy M, Lawrence JB, et al. A long noncoding RNA mediates both activation and repression of immune response genes. Science 2013; 341:789–92; PMID:23907535; http://dx. doi.org/10.1126/science.1240925
45. Gordon S, Akopyan G, Garban H, Bonavida B. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 2006; 25:1125–42; PMID:16314846; http://dx.doi.org/10.1038/sj.onc.1209080
46. Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J, Cheng A, Hall BM, Qualman SJ, Chandler DS, et al. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 2008; 14:369–81; PMID:18977326; http://dx.doi.org/10.1016/j.ccr.2008.10.006
47. Huerta-Yepez S, Vega M, Garban H, Bonavida B. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis. Clin Immunol 2006; 120:297–309; PMID:16784892; http://dx.doi.org/10.1016/j.clim.2006.03.015
48. Siednienko J, Maratha A, Yang S, Mitkiewicz M, Miggin SM, Moynagh PN. Nuclear factor kappaB subunits RelB and cRel negatively regulate Toll-like receptor 3-mediated beta-interferon production via induction of transcriptional repressor protein YY 1. J Biol Chem 2011; 286:44750–63; PMID:22065573; http://dx.doi.org/10.1074/jbc.M111.250894
49. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006; 6:508–19; PMID:16778830; http://dx.doi.org/10.1038/nri1882
50. Vausort M, Wagner DR, Devaux Y. Long Noncoding RNAs in Patients With Acute Myocardial Infarction. Circulation Research 2014; 115:668–U180; PMID:25035150; http://dx.doi.org/10.1161/CIRCRESAHA.115.303836
51. Zeuke S, Ulmer AJ, Kusumoto S, Katus HA, Heine H. TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS. Cardiovasc Res 2002; 56:126–34; PMID:12237173; http://dx.doi.org/10.1016/S0008-6363(02)00512-6
52. Song C, Hsu K, Yamen E, Yan W, Fock J, Witting PK, Geczy CL, Freedman SB. Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes. Atherosclerosis 2009; 207:374–83; PMID:19535079; http://dx.doi.org/10.1016/j.atherosclerosis.2009.05.007
53. Kaplanski G, Marin V, Montero-Julian F, Mantovani A, Farnarier C. IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol 2003; 24:25–9; PMID:12495721; http://dx.doi.org/10.1016/S1471-4906(02)00013-3
54. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336:1066–71; PMID:9091804; http://dx.doi.org/10.1056/NEJM199704103361506
55. Zhang X, Ding L, Sandford AJ. Selection of reference genes for gene expression studies in human neutrophils by real-time PCR. BMC Mol Biol 2005; 6:4; PMID:15720708; http://dx.doi.org/10.1186/1471-2199-6-4
56. Wang L, Feng Z, Wang X, Wang X, Zhang X. DEGseq: an R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics 2010; 26:136–8; PMID:19855105; http://dx.doi.org/10.1093/bioinformatics/btp612
57. Klipper-Aurbach Y, Wasserman M, Braunspiegel-Weintrob N, Borstein D, Peleg S, Assa S, Karp M, Benjamini Y, Hochberg Y, Laron Z. Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Med Hypotheses 1995; 45:486–90; PMID:8748093; http://dx.doi.org/10.1016/0306-9877(95)90228-7
58. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003; 100:9440–5; PMID:12883005; http://dx.doi.org/10.1073/pnas.1530509100
59. Hu FY, Wu C, Li Y, Xu K, Wang WJ, Cao HQ, Tian XL. AGGF1 is a novel anti-inflammatory factor associated with TNF-alphainduced endothelial activation. Cellular Signalling 2013; 25:1645–53; PMID:23628701; http://dx.doi.org/10.1016/j.cellsig.2013.04.007
60. Nelson JD, Denisenko O, Sova P, Bomsztyk K. Fast chromatin immunoprecipitation assay. Nucleic Acids Res 2006; 34:e2; PMID:16397291; http://dx.doi.org/10.1093/nar/gnj004
61. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007; 129:1311–23; PMID:17604720; http://dx.doi.org/10.1016/j.cell.2007.05.022
62. Niranjanakumari S, Lasda E, Brazas R, Garcia-Blanco MA. Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo. Methods 2002; 26:182–90; PMID:12054895; http://dx.doi.org/10.1016/S1046-2023(02)00021-X
63. Chu C, Quinn J, Chang HY. Chromatin isolation by RNA purification (ChIRP). J Vis Exp 2012
64. Engreitz J, Lander ES, Guttman M. RNA antisense purification (RAP) for mapping RNA interactions with chromatin. Methods Mol Biol 2015; 1262:183–97; PMID:25555582; http://dx.doi.org/10.1007/978-1-4939-2253-6_11
65. Kaida D, Berg MG, Younis I, Kasim M, Singh LN, Wan L, Dreyfuss G. U1 snRNP protects pre-mRNAs from premature cleavage and polyadenylation. Nature 2010; 468:664–8; PMID:20881964; http://dx.doi.org/10.1038/nature09479